NASDAQ:AGLE
Delisted

Aeglea Biotherapeutics Stock News

etoro logo Buy AGLE
*Your capital is at risk
$12.01
+0 (+0%)
At Close: Feb 26, 2024
In a report released today, Soumit Roy from JonesTrading reiterated a Buy rating on Aeglea Biotherapeutics (AGLE), with a price target of $22.00. The
In a report released today, Soumit Roy from JonesTrading reiterated a Buy rating on Aeglea Biotherapeutics (AGLE – Research Report),
In a report released today, Soumit Roy from JonesTrading reiterated a Buy rating on Aeglea Biotherapeutics (AGLE). The company's shares closed last Monday
In a report released today, Soumit Roy from JonesTrading reiterated a Buy rating on Aeglea Biotherapeutics (AGLE – Research Report).
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE